Stock Fundamentals

Company Information

Company Name
Neurogene Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US64135M1053
CIK: 0001404644
CUSIP: 64135M105
Currency: USD
Full Time Employees: 131
Phone: 855 508 3568
Fiscal Year End: December
IPO Date: Mar 07, 2014
Description:

Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.

Address:

535 W 24th Street, New York, NY, United States, 10011

Directors & Officers

Name Title Year Born
Dr. Rachel L. McMinn Ph.D. Founder, Executive Chair & CEO 1973
Ms. Christine Mikail Cvijic J.D. President, CFO & Director 1978
Dr. Julie Jordan M.D. Chief Medical Officer 1972
Dr. Stuart Cobb Ph.D. Chief Scientific Officer 1971
Ms. Donna M. Cochener-Metcalfe J.D., L.L.M. Senior VP, General Counsel & Corporate Secretary 1975
Dr. Andrew E. Mulberg CPI, FAAP, M.D. Senior VP of Regulatory Affairs, Quality Assurance & Quality Control NA
Mr. Ricardo Jimenez Senior Vice President of Technical Operations NA
Mr. Arvind Sreedharan Senior Vice President of Business Operations NA
Ms. Christina Shafer Chief Commercial Officer 1976

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 13, 2026 Christine Mikail Cvijic N/A Sale 4.05K $20.81 $84.18K
Mar 13, 2026 Stuart Cobb N/A Sale 6.80K $20.81 $141.45K
May 14, 2025 Stuart Cobb N/A Sale 6.80K $15.15 $102.97K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Samsara BioCapital, LLC 1.72M Mar 31, 2026 10.87% $3.36 0.00%
Redmile Group, LLC 1.46M Mar 31, 2026 9.24% $1.95 0.00%
Casdin Capital, LLC 1.42M Mar 31, 2026 8.99% $2.17 9.65%
RTW INVESTMENTS, LLC 1.36M Mar 31, 2026 8.62% $0.27 0.00%
EcoR1 Capital, LLC 1.27M Mar 31, 2026 8.05% $1.09 0.00%
BlackRock Inc 1.01M Mar 31, 2026 6.36% $0.00 6.29%
Baker Bros Advisors LP 991.69K Mar 31, 2026 6.28% $0.11 0.00%
Trails Edge Capital Partners, LP 782.79K Mar 31, 2026 4.95% $3.62 -0.28%
Balyasny Asset Management LLC 718.39K Mar 31, 2026 4.55% $0.02 18.04%
The Toronto-Dominion Bank 681.34K Mar 31, 2026 4.31% $0.02 0.00%
Vanguard Group Inc 656.57K Dec 31, 2025 4.16% $0.00 8.59%
Jennison Associates LLC 527.69K Mar 31, 2026 3.34% $0.01 -1.01%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 524.80K Mar 31, 2026 3.32% $0.28 -9.12%
Vanguard Capital Management, LLC 514.73K Mar 31, 2026 3.26% $0.00 0.00%
Great Point Partners LLC 500.00K Mar 31, 2026 3.16% $2.32 42.86%
Citadel Advisors Llc 387.03K Mar 31, 2026 2.45% $0.00 6.26%
FMR Inc 382.65K Mar 31, 2026 2.42% $0.00 193.60%
State Street Corp 313.01K Mar 31, 2026 1.98% $0.00 1.69%
Morgan Stanley - Brokerage Accounts 285.24K Mar 31, 2026 1.81% $0.00 -23.15%
Geode Capital Management, LLC 279.00K Mar 31, 2026 1.77% $0.00 11.74%

Shares Statistics

Shares Outstanding: 19.95M
Shares Float: 8.83M
% Insiders: 707.20%
% Institutions: 8,849.10%
Short % Float: 26.44%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 382.19K 2.42% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 271.51K 1.72% ▲ 0.93% May 29, 2026
3 Fidelity Advisor Biotechnology I 243.70K 1.54% ▲ 0.00% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 120.53K 0.76% ▲ 0.00% Apr 30, 2026
5 Fidelity Small Cap Index 111.00K 0.70% ▲ 15.28% Mar 31, 2026
6 Stt Strt®SPDR®S&PKenshoNwEcosComposETF 100.70K 0.64% ▼ 0.37% May 29, 2026
7 iShares Russell 2000 Value ETF 96.15K 0.61% ▲ 0.00% May 29, 2026
8 iShares Biotechnology ETF 91.70K 0.58% ▲ 1.96% May 29, 2026
9 Fidelity Enhanced Small Cap Core ETF 84.11K 0.53% ▲ 0.25% May 29, 2026
10 Meridian Small Cap Growth Legacy 75.86K 0.48% ▼ 33.10% Mar 31, 2026

Valuation Metrics

Enterprise Value: $621.03M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $854.67M
EBITDA: $-107.45M
Book Value: $15.23
Earnings/Share: $-4.20
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -23.91%
ROE (TTM): -37.25%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 16.56x 0.01x 0.08x -20,641.60x -0.04x
2024-12-31 20.84x 0.01x 0.08x -6,883.75x -0.04x
2023-12-31 8.72x 0.02x 0.16x -4,631.92x -0.09x
2022-12-31 12.74x 0.01x 0.10x -28,258.50x -0.01x
2021-12-31 6.81x -0.02x 1.91x N/A -0.04x
2020-12-31 24.66x 0.00x 0.09x N/A -0.02x
2019-12-31 30.28x 0.00x 0.04x -24,443.00x -0.01x
2018-12-31 16.68x 0.00x 0.06x -5,881.00x 0.00x
2017-12-31 9.93x 0.00x 0.10x -12,779.75x 0.00x
2016-12-31 10.87x 0.00x 0.06x -37,645.00x 0.00x
2015-12-31 15.61x 0.00x 0.04x -215.56x 0.00x
2014-12-31 7.55x 0.00x 0.13x -9.96x 0.00x
2013-12-31 21.77x 0.00x 0.13x -218.43x -0.03x
2012-12-31 5.36x 0.00x 0.63x N/A 0.00x
2011-12-31 15.61x 0.00x 0.13x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NGNE.US!